| Website | qthera.com |
| Category | BioTech |
| Employees |
| TOTAL | $8M |
| FUNDING TOTAL | $8M |
| Series B, 2/08 vSpring Capital Invitrogen Epic Ventures Toucan Capital University of Utah Endowment Salt Lake Life Science Angels Q management | $8M |
Q Therapeutics is an emerging biopharmaceutical company that utilizes cell-based technologies to develop new treatments for debilitating diseases of the central nervous system (CNS). Their company was founded based on the pioneering work of Dr. Mahendra Rao at the University of Utah. In 2004, they began the process of translating decades of research at the University of Utah and the National Institute of Health (NIH) into practical new therapeutic products. Their exclusive licenses with these institutions have resulted in 16 issued patents, with many more pending.
